살부타몰 경구용 액체 시장 보고서(2025년)
Salbutamol Oral Liquid Global Market Report 2025
상품코드 : 1769741
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

살부타몰 경구용 액체 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 배출량 증가, 알레르기성 호흡기 질환의 빈도 증가, 액체 투여 형태로의 경사 증가 등이 있습니다.

호흡기 질환 증가는 향후 몇 년 동안 살부타몰 경구용 액체 시장의 성장을 가속화할 것으로 예측됩니다. 증가는 대기오염의 확대나 환경오염물질에의 노출이 주된 원인이 되고 있습니다. 살부타몰 경구용 액체는 기도 근육을 이완시키고 기관지 경련을 완화하며 공기 흐름을 개선하는 데 일반적으로 사용되며, 천명음, 호흡 곤란, 가슴 답답함과 같은 증상을 완화하는 데 도움이 됩니다. 2023년 11월, 호주 국립 천식 협회(National Asthma Council Australia)는 2022년에 호주에서 467명의 천식 관련 사망자가 발생했다고 보고했는데, 이는 2021년 355명에서 증가한 수치이며, 여성 299명과 남성 168명이 포함됩니다.

의료비 지출 증가는 살부타몰 경구용 액체 시장의 확대를 지원할 것으로 예측되고 있습니다. 의료비 지출은 병원 진료, 의사 방문, 약물 복용, 공중 보건 프로그램 등 의료 서비스 및 제품에 대한 총 지출을 포함합니다. 의료 비용 증가는 종종 선진 의료 및 기술의 도입과 관련이 있습니다. 의료비 지출 증가는 필수 호흡기 약물에 대한 접근성을 높이고 천식 및 COPD와 같은 질환의 진단 및 치료를 용이하게 하며, 특히 자원이 부족한 지역에서 기관지 확장제의 광범위한 배포를 가능하게 함으로써 살부타몰 경구용 액체 시장에 도움이 될 수 있습니다. 예를 들어, 2024년 5월 영국 통계청은 2022년부터 2023년까지 총 의료비 지출이 명목 5.6% 증가했다고 보고했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Salbutamol oral liquid refers to a medication formulation containing salbutamol, a bronchodilator that helps relax the muscles in the airways. It is used for the relief and prevention of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).

The primary types of salbutamol oral liquid include oral liquid solutions and oral liquid suspensions. Oral liquid solutions of salbutamol are bronchodilator drugs in liquid form, commonly utilized to alleviate symptoms of asthma, bronchitis, and other obstructive respiratory conditions by relaxing airway muscles and enhancing airflow to the lungs. These formulations come in various forms such as syrup, solution, and concentrate, and contain active components like albuterol, levalbuterol, pirbuterol, salmeterol, and formoterol. The distribution of salbutamol oral liquids takes place through multiple channels including hospital pharmacies, retail pharmacies, and online pharmacies, and they are used to treat asthma, COPD, and various other respiratory ailments.

The salbutamol oral liquid market research report is one of a series of new reports from The Business Research Company that provides salbutamol oral liquid market statistics, including the salbutamol oral liquid industry global market size, regional shares, competitors with the salbutamol oral liquid market share, detailed salbutamol oral liquid market segments, market trends, and opportunities, and any further data you may need to thrive in the salbutamol oral liquid industry. This salbutamol oral liquid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The salbutamol oral liquid market size has grown strongly in recent years. It will grow from $1.11 billion in 2024 to $1.17 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The expansion during the historical period was driven by factors such as a rising number of asthma cases, increased public awareness of chronic respiratory illnesses, a growing elderly population, heightened demand for pediatric respiratory therapies, and escalating air pollution levels causing respiratory health issues.

The salbutamol oral liquid market size is expected to see strong growth in the next few years. It will grow to $1.45 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. Factors contributing to this projected growth include broader acceptance of online pharmacy platforms, heightened public education on asthma control, increased healthcare expenditures, a higher frequency of allergic respiratory conditions, and an increased inclination towards liquid dosage forms. Key trends expected during this period involve the development of innovative formulations, integration of digital tracking in packaging, customized dosing technologies, cloud-integrated supply networks, and eco-friendly packaging solutions.

The increasing incidences of respiratory disorders are expected to drive the growth of the salbutamol oral liquid market in the coming years. Respiratory disorders, which affect the lungs and airways, hinder breathing and the body's ability to exchange oxygen. A rise in these disorders is largely attributed to growing air pollution and exposure to environmental pollutants. Salbutamol oral liquid is commonly used in the treatment of respiratory disorders to relax airway muscles, ease bronchospasms, and improve airflow, helping to relieve symptoms such as wheezing, shortness of breath, and chest tightness. For example, in November 2023, the National Asthma Council Australia reported that Australia experienced 467 asthma-related deaths in 2022-299 females and 168 males-up from 355 deaths in 2021. As a result, the growing number of respiratory disorders is boosting the demand for salbutamol oral liquid.

The increase in healthcare expenditures is anticipated to support the expansion of the salbutamol oral liquid market. Healthcare expenditures encompass the total spending on medical services and products, such as hospital care, physician visits, medications, and public health programs. Rising healthcare costs are often linked to the adoption of advanced medical treatments and technologies. Higher healthcare spending can benefit the salbutamol oral liquid market by enhancing access to essential respiratory medications, facilitating the diagnosis and treatment of conditions like asthma and COPD, and enabling broader distribution of bronchodilators, particularly in under-resourced regions. For instance, in May 2024, the UK's Office for National Statistics reported a 5.6% nominal increase in total healthcare expenditure from 2022 to 2023, a significant rise compared to the 0.9% growth in 2022. This trend in rising healthcare investments is thus contributing to the growth of the salbutamol oral liquid market.

The increase in air pollution is projected to further fuel the salbutamol oral liquid market's growth. Air pollution involves the presence of harmful airborne substances that pose risks to human health, ecosystems, and the climate. This pollution is increasingly driven by emissions from industrial processes and fossil fuel combustion. Salbutamol oral liquid helps mitigate breathing difficulties caused by air pollution by relaxing airway muscles and improving airflow to the lungs. For instance, in October 2023, the UK Office for National Statistics noted a 2% year-over-year increase in greenhouse gas emissions on a residence basis from 2021 to 2022. Consequently, the growing levels of air pollution are contributing to the rising demand for salbutamol oral liquid.

Major players in the salbutamol oral liquid market are GlaxoSmithKline plc, Cipla Limited, Lupin Limited, Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Limited, Beta Healthcare International Limited, Sakar Healthcare Limited, Pharmatec Pakistan (Private) Limited, Infinity Pharma, Azaria Pharmaceutical Laboratories Inc., Salvavidas Pharmaceutical Private Limited, Lucky Pharmaceuticals, Wellona Pharma, Centurion Healthcare Private Limited, Niksan Pharmaceutical, SUNWARD PHARMACEUTICAL SDN. BHD., Glumex Pharmaceuticals Mfg. Pvt. Ltd., Indo Rama Engineers, Elikem Pharmaceuticals Private Limited, and CCI Products.

North America was the largest region in the salbutamol oral liquid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in salbutamol oral liquid report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the salbutamol oral liquid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The salbutamol oral liquid market consists of sales of ventolin syrup, asthalin syrup, salbetol syrup, bronkotab syrup, salbulin syrup, ventair syrup. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Salbutamol Oral Liquid Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on salbutamol oral liquid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for salbutamol oral liquid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The salbutamol oral liquid market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Salbutamol Oral Liquid Market Characteristics

3. Salbutamol Oral Liquid Market Trends And Strategies

4. Salbutamol Oral Liquid Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Salbutamol Oral Liquid Growth Analysis And Strategic Analysis Framework

6. Salbutamol Oral Liquid Market Segmentation

7. Salbutamol Oral Liquid Market Regional And Country Analysis

8. Asia-Pacific Salbutamol Oral Liquid Market

9. China Salbutamol Oral Liquid Market

10. India Salbutamol Oral Liquid Market

11. Japan Salbutamol Oral Liquid Market

12. Australia Salbutamol Oral Liquid Market

13. Indonesia Salbutamol Oral Liquid Market

14. South Korea Salbutamol Oral Liquid Market

15. Western Europe Salbutamol Oral Liquid Market

16. UK Salbutamol Oral Liquid Market

17. Germany Salbutamol Oral Liquid Market

18. France Salbutamol Oral Liquid Market

19. Italy Salbutamol Oral Liquid Market

20. Spain Salbutamol Oral Liquid Market

21. Eastern Europe Salbutamol Oral Liquid Market

22. Russia Salbutamol Oral Liquid Market

23. North America Salbutamol Oral Liquid Market

24. USA Salbutamol Oral Liquid Market

25. Canada Salbutamol Oral Liquid Market

26. South America Salbutamol Oral Liquid Market

27. Brazil Salbutamol Oral Liquid Market

28. Middle East Salbutamol Oral Liquid Market

29. Africa Salbutamol Oral Liquid Market

30. Salbutamol Oral Liquid Market Competitive Landscape And Company Profiles

31. Salbutamol Oral Liquid Market Other Major And Innovative Companies

32. Global Salbutamol Oral Liquid Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Salbutamol Oral Liquid Market

34. Recent Developments In The Salbutamol Oral Liquid Market

35. Salbutamol Oral Liquid Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기